Evidence map›Paper›PMID 36560890›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2023

Stem Cell Membrane-Coated Microribbon Scaffolds Induce Regenerative Innate and Adaptive Immune Responses in a Critical-Size Cranial Bone Defect Model.

Ni Su, Cassandra Villicana, Danial Barati, Peyton Freeman, Ying Luo, Fan Yang

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Biodegradable MgBioactive materials · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Biomimetic Cell Membrane-Coated Scaffolds for Enhanced Tissue Regeneration.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  17. Article
  18. Research Progress on Biomaterials with Immunomodulatory Effects in Bone Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ni SuDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID https://orcid.org/0000-0002-6207-596X
Cassandra VillicanaDepartment of Bioengineering, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Danial BaratiDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Peyton FreemanDepartment of Bioengineering, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Ying LuoDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts, 02155, USA.
Fan YangDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID https://orcid.org/0000-0002-0418-0403

Funding

Microribbon scaffold-mediated Immunomodulation for Cranial Bone RepairR01DE024772 · NIDCR · STANFORD UNIVERSITY · PI YANG, FAN · 2015 to 2025
$4.6M
Sliding hydrogels for accelerating cartilage regenerationR01AR074502 · NIAMS · STANFORD UNIVERSITY · PI YANG, FAN · 2019 to 2023
$2.2M
Graduate Training Program in BiotechnologyT32GM141819 · NIGMS · STANFORD UNIVERSITY · PI Eric Andrew Appel, Fan Yang · 2021 to 2026
$1.9M
EDGE FellowshipNational Science Foundation Predoctoral fellowshipNIAMS NIH HHS R01 AR074502NIDCR NIH HHS R01 DE024772NIGMS NIH HHS T32 GM141819NIH HHS R01AR074502NIH HHS R01DE024772Stanford Maternal and Children's Health Institute Postdoctoral Fellowship
6 · The paper itself

Abstract

Naturally-derived cell membranes have shown great promise in functionalizing nanoparticles to enhance biointerfacing functions for drug delivery applications. However, its potential for functionalizing macroporous scaffolds to enhance tissue regeneration in vivo remains unexplored. Engineering scaffolds with immunomodulatory functions represents an exciting strategy for tissue regeneration but is largely limited to soft tissues. Critical-sized bone defects cannot heal on their own, and the role of adaptive immune cells in scaffold-mediated healing of cranial bone defects remains largely unknown. Here, mensenchymal stem cell membrane (MSCM)-coated microribbon (µRB) scaffolds for treating critical size cranial bone defects via targeting immunomodulation are reported. Confocal imaging and proteomic analyses are used to confirm successful coating and characterize the compositions of cell membrane coating. It is demonstrated that MSCM coating promotes macrophage (Mφ) polarization toward regenerative phenotype, induces CD8+ T cell apoptosis, and enhances regulatory T cell differentiation in vitro and in vivo. When combined with a low dosage of BMP-2, MSCM coating further accelerates bone regeneration and suppresses inflammation. These results establish cell membrane-coated microribbon scaffolds as a promising strategy for treating critical size bone defects via immunomodulation. The platform may be broadly used with different cell membranes and scaffolds to enhance regeneration of multiple tissue types.

Indexed as

ProteomicsTissue ScaffoldsBone RegenerationCell MembraneOsteogenesisSkullStem CellsTissue Engineeringbiomaterialsbone regenerationcell membrane coatingcritical-sized bone defectsimmunomodulation

Identifiers

PMID36560890
PMCPMC10057912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.